USO Surges, This Year Still Losing the Long Game Ahead
USO has jumped 64% year to date, yet its long-term track record flags a stubborn drag from futures contango. Analysts...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,457 articlesUSO has jumped 64% year to date, yet its long-term track record flags a stubborn drag from futures contango. Analysts...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
As BLV pays a steady 4.77% yield, retirees confront a trade-off between dependable income and potential principal swi...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
HUD’s annual report acts like a health check for the FHA program. This article breaks down what the 2026 outlook mean...
The VanEck BDC Income ETF offers a high 13% quarterly yield by investing in business development companies. Yet the f...
From a memoir announcement to a heartfelt birthday tribute, this guide turns a focal family moment into actionable fi...
The NEOS QQQI ETF paid out $7.63 per share in the last 12 months, yet the fund trailed the Nasdaq-100 rally as invest...
VOOG surged in a blistering rally before facing headwinds as rates climbed and big tech leadership shifted. Here's wh...
Huge IPO rumors around SpaceX could change the way S&P 500 ETFs are built. This guide explains how inclusion works, w...
AMLP offers a steady, roughly 7% yield from energy infrastructure. This article explains why most retirees overlook A...